G. Sutter

Population pharmacokinetic/pharmacodynamic evaluation of low-dose drospirenone with 17&bgr;-estradiol in postmenopausal women with moderate to severe vasomotor symptoms

C. Gerlinger, D. Archer, T. Schmelter, 2014, Menopause.

Population Pharmacokinetics of Nifurtimox in Adult and Pediatric Patients With Chagas Disease

H. Stass, S. Willmann, I. Ince, 2022, Journal of clinical pharmacology.

Application of Physiologically‐Based and Population Pharmacokinetic Modeling for Dose Finding and Confirmation During the Pediatric Development of Moxifloxacin

T. Eissing, J. Lippert, H. Stass, 2019, CPT: pharmacometrics & systems pharmacology.

Evaluation of possible drug–drug interaction between gadoxetic acid and erythromycin as an inhibitor of organic anion transporting peptides (OATP)

B. Hamm, A. Huppertz, M. Schultze-Mosgau, 2011, Journal of magnetic resonance imaging : JMRI.

Assessment of the safe and efficacious dose of the selective progesterone receptor modulator vilaprisan for the treatment of patients with uterine fibroids by exposure–response modelling and simulation

B. Ploeger, M. Schultze-Mosgau, C. Seitz, 2021, British journal of clinical pharmacology.

Pharmacokinetics and Safety of Macrocyclic Gadobutrol in Children Aged Younger Than 2 Years Including Term Newborns in Comparison to Older Populations

H. Mentzel, M. Stenzel, Marta Santiuste, 2016, Investigative radiology.

From Adults to Children

S. Reif, M. Schultze-Mosgau, Gabriele Sutter, 2012, Pediatric Drugs.